FDA approves Novo Nordisk's diabetes drugs

A person receives a test for diabetes during Care Harbor LA free medical clinic in Los Angeles, California September 11, 2014. REUTERS/Mario Anzuoni

The U.S. Food and Drug Administration said it approved two diabetes drugs from Danish drugmaker Novo Nordisk A/S to be marketed in the country.

The FDA approved the drugs, Tresiba and Ryzodeg, with a warning that they should not be used in patients who have high levels of the chemical ketone.